LL-37 peptide
| Name | LL-37 | ||||||
| Sequence | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| 3-letter-code | Leu - Leu - Gly - Asp - Phe - Phe - Arg - Lys - Ser - Lys - Glu - Lys - Ile - Gly - Lys - Glu - Phe - Lys - Arg - Ile - Val - Gln - Arg - Ile - Lys - Asp - Phe - Leu - Arg - Asn - Leu - Val - Pro - Arg - Thr - Glu - Ser | ||||||
| Notes | >95% purity. Also available as LL-37 : Ultra-pure at >98% purity. | ||||||
| Molecular weight | 4493.33 | ||||||
| Counter ion | TFA | ||||||
| Solubilization | Soluble in pure water. | ||||||
| Description | The cathelicidin anti-microbial peptide LL-37 corresponds to aa 134-170 of the human cationic antimicrobial protein 18 (hCAP18). | ||||||
| References | M. Chromek, Z. Slamová, P. Bergman, L. Kovács, L. Podracká, I. Ehrén, T. Hökfelt, G.H. Gudmundsson, R.L. Gallo, B. Agerberth & A. Brauner. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nature Medicine 2006 12:636-641 L. Bandholtz, G. Jacobsson Ekman, M. Vilhelmsson, E. Buentke, B. Agerberth, A. Scheynius, G. H. Gudmundsson. 2006. Antimicrobial Peptide LL-37 Internalized by Immature Human Dendritic Cells Alters their Phenotype. Scandinavian Journal of Immunology 63 (6), 410419. |
||||||
Order LL-37 peptide
| Amount | Cat.No. | Unit price | |||||
|---|---|---|---|---|---|---|---|
| 1 mg | SP-LL37-1 | 300 EUR | BUY | ||||
| 1 mg x 2 | SP-LL37-1x2 | 430 EUR | BUY | ||||
| 5 mg | SP-LL37-5 | 830 EUR | BUY | ||||
| For larger amounts please inquire. | |||||||
Labeled and modified LL-37
| Name | |||||||
|---|---|---|---|---|---|---|---|
| LL-37 5-FAM | 5-Carboxyfluorescein on N-terminus. | ||||||
| LL-37 5-TAMRA | 5-Carboxytetramethylrhodamine on N-terminus. | ||||||
| LL-37 biotin | Biotin via a 6-carbon spacer (Ahx) on N-terminus. | ||||||
| LL-37 Lys 5-TAMRA | LL-37 with 5-TAMRA labeled Lysine at C-terminus. Amide on C-terminus. | ||||||
| LL-37 reverse | Reverse sequence of LL-37. | ||||||
| LL-37 scrambled | Scrambled version of LL-37. | ||||||
LL-37 antibody
| Information |
|---|
| LL-37 antibody product description |
LL-37 affinity columns
| Affinity columns are custom made depending on your requirements. Please inquire for more information. |
| Information |
|---|
| Inquire for LL-37 peptide affinity column |
| Inquire for LL-37 antibody affinity column |
Related peptides
| Name | Sequence | ||||||
|---|---|---|---|---|---|---|---|
| Cys-LL-37 | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| Cys-LL-37-Cys | CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
| LL-37 (acetate) | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 : Ultra-pure | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 Citrulline | LLGDFF(Cit )KSKEKIGKE FK(Cit)IVQ (Cit)IKDFL (Cit)NLVP( Cit)TES | ||||||
| LL-37 FK-13 | FKRIVQRIKDFLR | ||||||
| LL-37 FKR | FKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 GKE | GKEFKRIVQRIKDFLRNLVPR | ||||||
| LL-37 KRI | KRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 LLG | LLGDFFRKSKEKIGKEFKRIV | ||||||
| LL-37 RKS | RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | ||||||
| LL-37 SKE | SKEKIGKEFKRIVQRIKDFLR | ||||||
| LL-37-Cys | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC | ||||||
